A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
Sign Up to like & getrecommendations! Published in 2021 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2021.07.007
Abstract: Pulmonary arterial hypertension (PAH) - a complex and progressive disease that carries significant morbidity and mortality despite optimal medical treatment. Combination therapy for PAH can be more effective than monotherapy. The present randomized trial compared… read more here.
Keywords: combination; eisenmenger syndrome; ambrisentan combination; combination therapy ... See more keywords